Novo Nordisk (NOVOB DC) FDA approved GLP-1 is now available with Hims and Hers (HIMS)
Every headline is on the live feed 20 minutes before this site.
BoE's Taylor says current energy shock looks more like 2011 than 2022 in terms of magnitude; currently sees a high bar to hiking
US President Trump, asked if the US was going to go in to do something, says he cannot answer that
Novo Nordisk (NOVOB DC) FDA approved GLP-1 is now available with Hims and Hers (HIMS)
Furious Republicans reportedly stormed out of a classified briefing on Iran on Wednesday amid fears the US is preparing to invade the country as Tehran refuses Trump's peace overtures, Daily Mail reports
Turkey sold or swapped 58 tonnes of Gold in 2 weeks to March 20th
On the Newsquawk feed at , 20 minutes before this page.
Context
Novo Nordisk's FDA approval for their GLP-1 treatment in collaboration with Hims and Hers marks a significant expansion of their product offerings in a competitive market. This partnership could enhance Novo's revenue streams while also positioning Hims and Hers as a more comprehensive provider of healthcare solutions. Market reaction may hinge on expectations for the GLP-1 treatment's uptake and the impacts on both companies' competitive positioning in the healthcare landscape.
Related headlines
- Weekly US Earnings Estimates: 19th-23rd October 2026: Earnings pick up with META, TSLA, SPCX, LRCX, and NFLX the highlights1 day ago
- Nvidia (NVDA) expands tools for building AI-powered games with Unreal Engine 51 day ago
- US FAA is set to approve certification for the Boeing (BA) 737 MAX 10, sources report; potentially as soon as in the next week1 day ago
- Daily US Earnings Estimates: 19th October 2026: FITB, WRB, and STLD1 day ago
- T-Mobile (TMUS) downside attributed to a terminated relationship with SpaceX (SPCX) - UNCONFIRMED1 day ago
- Michael Dell (DELL) expects memory crunch to get worse, WSJ reports1 day ago
- US officials pressed Beijing on market access issues for Mastercard (MA) and Citigroup (C) during at least two bilateral meetings with Chinese counterparts in Bangkok this week, CNBC reports, citing a source1 day ago
- Apple (AAPL) set for UK legal fight over iPhone tap-to-pay rules, FT reports1 day ago
- US EQUITY OPEN: Stocks mixed at the open as AI stock rout continues1 day ago
- US DoJ officials have reportedly signalled their preference to settle antitrust lawsuit against Apple (AAPL), The Information reports citing sources1 day ago
- Daily US Equity Opening News: 16th October 2026: TSLA gains on Roadster reveal; NFLX slips as Content Chief to leave; TRV earnings underwhelm1 day ago
- US PREMARKET MOVERS: TSLA, NFLX, VRNS, AA, TRV, MSTR, WDAY, ECHO1 day ago
- Charles Schwab (SCHW) CEO says seeing record levels of interest in fixed income; Brokerage is blocking unauthorised AI agents1 day ago
- Apple (AAPL) iPhone duo delivery date slips to January 25th1 day ago
- US BROKER MOVES: CPRI upgrade at Raymond James; WDAY downgraded at KeyBanc1 day ago
- Apple's (AAPL) iPhone Duo sells out minutes after pre-orders open, according to Apple Insider1 day ago
- ExxonMobil (XOM) says changes in margins to impact Q3 chemical products earnings by USD -0.6bln Q/Q1 day ago
- Marqeta (MQ) and Coinbase (COIN) to enable stablecoin-backed card payments1 day ago
- Nvidia's (NVDA) RTX Spark laptops have launched globally, starting at USD 2,5991 day ago
- Travelers (TRV) Q3 2026 (USD): Adj. EPS 9.18 (exp. 7.39), Revenue 12.4bln (exp. 11.4bln); Net Premiums Written 11.48bln (exp. 11.40bln), Catastrophe Loss 538mln (exp. 695mln)1 day ago
The feed had this first.
Use the Platform